深部脑刺激治疗精神疾病的PET分子影像系统综述
本文系统综述PubMed、Web of Science和Scopus数据库中应用PET研究深部脑刺激(DBS)治疗难治性精神疾病效果的原研文献。初检149篇,最终纳入27项研究,涵盖抑郁症11项、强迫症8项、物质使用障碍3项、神经性厌食3项、精神分裂症1项。PET示踪剂显示DBS前后脑内分子改变,信号变化多与精神症状评分改善相关。
要点
- PET可反映DBS前后脑内分子活动改变,信号变化多与症状评分改善相关
- 不同DBS靶点的PET激活模式各异,其临床意义尚不明确
- PET有望用于DBS患者筛选、预后判断与长期监测
核心结论
- PET可揭示DBS对脑分子活动的影响,可能有助于改善患者筛选、预后判断和长期监测。
研究设计与样本
- 系统综述,检索PubMed、Web of Science和Scopus数据库,初检149篇,最终纳入27项原研研究进行定性分析。
主要发现
- 纳入研究包括抑郁症11项、强迫症8项、物质使用障碍3项、神经性厌食3项、精神分裂症1项。
- 18F-FDG(葡萄糖代谢)、15O-water(脑血流)、11C-raclopride(多巴胺传递)等示踪剂显示DBS前后存在不同的分子改变。
- PET信号变化通常与精神症状评分的临床改善相关。
- 不同脑区DBS靶点的PET激活模式各异,但其临床意义尚不明确。
临床怎么用
- 对于难治性精神疾病患者,PET分子影像可作为评估DBS效果与随访监测的辅助手段,但靶点选择仍需结合临床。
局限性
- 本文为定性系统综述,纳入研究数量有限(27项),且不同靶点PET改变的临床意义尚不明确。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Deep brain stimulation (DBS) is an evolving technique for the treatment of various psychiatric disorders refractory to conventional pharmacotherapy. Neuroimaging with positron emission tomography (PET) has an important role in the planning, delivery, and post-surgical monitoring of DBS. This study aims to determine the clinical relevance of PET as a biomarker of disease status and response to DBS for patients with psychiatric disorders. METHODS: We performed a systematic review of the PubMed, Web of Science, and Scopus databases to identify original research studies that applied PET to study the effects of DBS for patients with psychiatric conditions (major depressive disorder, obsessive-compulsive disorder (OCD), substance use disorder, anorexia nervosa, and schizophrenia). Information on study design, PET findings, clinical measures, and outcomes were recorded. RESULTS: From an initial search of 149 articles, we identified 27 studies on depression (n = 11), OCD (n = 8), substance use disorder (n = 3), anorexia nervosa (n = 3), and schizophrenia (n = 1) that met selection criteria for our qualitative analysis. PET imaging with various radiotracers (18F-fluorodeoxyglucose (FDG) for glucose metabolism, 15O-water for cerebral blood flow, 11C-raclopride for dopamine transmission) revealed distinct molecular alterations in patients before and after DBS. Changes in PET signal generally correlated with clinical improvements in psychiatric symptom scores. Comparisons of studies that targeted different brain structures for DBS demonstrated unique activation patterns on PET, though the clinical significance of these changes remains unclear. CONCLUSIONS: PET provides insight into the effects of DBS on the molecular activity of the brain, which may improve patient selection for surgery, prognostication, and long-term monitoring.
引用
- Patil S, Gerlach A, Jeevika F, et al. Deep Brain Stimulation for Psychiatric Disorders: A Systematic Review of Molecular Imaging with PET. World Neurosurg. 2026. PMID: 41921779. doi:10.1016/j.wneu.2026.124933
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。